TechNet-21 - Forum

  1. Alejandro Ramirez Gonzalez
  2. Programme management
  3. Tuesday, 04 October 2022

The Global Compendium of country knowledge on COVID-19 vaccination is now available. It aims at offering an organized information space that:

  • Facilitates countries, development partners, NGOs and entities supporting vaccine rollout, access to other country’s documented successes and challenges of their COVID-19 vaccination programmes; this would potentially inform about emerging issues in real-time and thus open a pathway for immediate solutions
  • Establishes a knowledge platform that creates an operational legacy to inform planning for expanding and strengthening vaccination across the life-course in non-emergency settings, as well as, in how emergency vaccination could be scaled-up in preparation of a future health crisis

Topics areas include

  • COVID19 vaccination country experiences
  • COVID19 vaccination country case studies
  • Country evaluations reviews, reports and publications

The Global Compendium is continually under development and country case studies continue to be sought. Should partners or colleagues like to contribute or share additional experiences or knowledge, please do not hesitate to reach out. For any comments or interest in collaborating, please contact me on TechNet-21 using direct message or by email to [email protected].  

We would like to thank all stakeholders involved, especially country and regional colleagues, for their active collaboration and sharing of materials.

Access and navigation: The above link will take directly to the compendium “sub-site” within the TechNet-21 platform. To navigate in the Compendium sub-site, please only use the navigation menu that is available on the right-hand side of each page (do not use the top banner as this will take you somewhere else in the TechNet-21 platform).

You can also access the page from any Technet-21 page, you will find the "COVID Compendium" under “Topics”  in the main navigation menu, at the top of the page. 


There are no replies made for this post yet.
Be one of the first to reply to this post!